Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1186/s12985-020-01347-5

http://scihub22266oqcxt.onion/10.1186/s12985-020-01347-5
suck pdf from google scholar
32552831!7298446!32552831
unlimited free pdf from europmc32552831    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32552831      Virol+J 2020 ; 17 (1): 77
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Challenge infection model for MERS-CoV based on naturally infected camels #MMPMID32552831
  • Alharbi NK; Ibrahim OH; Alhafufi A; Kasem S; Aldowerij A; Albrahim R; Abu-Obaidah A; Alkarar A; Bayoumi FA; Almansour AM; Aldubaib M; Al-Abdely HM; Balkhy HH; Qasim I
  • Virol J 2020[Jun]; 17 (1): 77 PMID32552831show ga
  • BACKGROUND: Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging virus that infects humans and camels with no approved antiviral therapy or vaccine. Some vaccines are in development for camels as a one-health intervention where vaccinating camels is proposed to reduce human viral exposure. This intervention will require an understanding of the prior exposure of camels to the virus and appropriate vaccine efficacy studies in camels. METHODS: We conducted a cross sectional seroprevalence study in young dromedary camels to determine the rate of MERS-CoV seropositivity in young camels. Next, we utilised naturally infected camels as a natural challenge model that can be used by co-housing these camels with healthy naive camels in a ratio of 1 to 2. This model is aimed to support studies on natural virus transmission as well as evaluating drug and vaccine efficacy. RESULTS: We found that 90% of the screened camels have pre-existing antibodies for MERS-CoV. In addition, the challenge model resulted in MERS-CoV transmission within 48 h with infections that continued for 14 days post challenge. CONCLUSIONS: Our finding suggests that the majority of young dromedary camels in Saudi Arabia are seropositive and that naturally infected camels can serve as a challenge model to assess transmission, therapeutics, and vaccine efficacy.
  • |*Disease Models, Animal[MESH]
  • |Animals[MESH]
  • |Antibodies, Viral/blood[MESH]
  • |Camelus/*virology[MESH]
  • |Coronavirus Infections/epidemiology/prevention & control/transmission/*veterinary[MESH]
  • |Cross-Sectional Studies[MESH]
  • |Middle East Respiratory Syndrome Coronavirus/*immunology[MESH]
  • |Saudi Arabia/epidemiology[MESH]
  • |Seroepidemiologic Studies[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box